ClinConnect ClinConnect Logo
Search / Trial NCT05183971

Proprioceptive Deficits in Degenerative Cervical Myelopathy

Launched by THE UNIVERSITY OF HONG KONG · Jan 4, 2022

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Degenerative Cervical Myelopathy Proprioceptive Deficits

ClinConnect Summary

This clinical trial is studying a condition called degenerative cervical myelopathy (DCM), which affects the ability to feel where your body is positioned, leading to problems with balance and movement. The goal of the study is to develop a simple and non-invasive way to assess proprioception—the sense that helps you know where your body is in space—specifically in people over 50 years old. By identifying early signs of DCM, the researchers hope to prevent more serious issues and disabilities that can come from this condition.

To be eligible for the trial, participants must be Chinese, aged 50 or older, and have evidence of DCM, even if they do not currently show symptoms. They should not have other serious conditions that could affect their movement or balance. If you join the study, you can expect to undergo some straightforward physical tests to check your balance and movement abilities. This research is important because it aims to improve early detection and help those at risk maintain a better quality of life.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Chinese
  • Aged 50 or above
  • With radiological evidence of degenerative cervical myelopathy, both symptomatic and asymptomatic
  • Nurick grade less than 3
  • Exclusion Criteria:
  • Non-Chinese ethnicity
  • Aged under 50
  • without any radiological proof of cervical myelopathy
  • Active problems of tuberculosis spine, lumbar spinal diseases, and other problems causing pain or deformities over the limbs that may affect their balance and movement
  • Presents with extra-pyramidal or other disorders involving the cerebellum or frontal lobe of the cerebrum leading to poor balance and gait disturbance
  • Previous spinal operation with residual disturbance in balance or gait
  • Non-communicable patients with insufficient cognitive ability to express their symptoms clearly
  • Non-walker
  • Blind or deaf

About The University Of Hong Kong

The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Karlen Ka Pui Law, M. Phil

Principal Investigator

The University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials